# Exploring the Minimum Effective Concentration and Volume of Ropivacaine for Sacral Plexus Anesthesia

> **NCT06711679** · PHASE4 · ENROLLING_BY_INVITATION · sponsor: **Yilin Zhao** · enrollment: 180 (estimated)

## Conditions studied

- Pediatric ALL

## Interventions

- **DRUG:** Low-dose ropivacaine
- **DRUG:** Medium-dose of ropivacaine
- **DRUG:** High-dose ropivacaine

## Key facts

- **NCT ID:** NCT06711679
- **Lead sponsor:** Yilin Zhao
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** ENROLLING_BY_INVITATION
- **Start date:** 2024-05-10
- **Primary completion:** 2024-12-20
- **Final completion:** 2026-03-20
- **Target enrollment:** 180 (ESTIMATED)
- **Last updated:** 2024-12-02

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06711679

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06711679, "Exploring the Minimum Effective Concentration and Volume of Ropivacaine for Sacral Plexus Anesthesia". Retrieved via AI Analytics 2026-06-12 from https://api.ai-analytics.org/clinical/NCT06711679. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*